A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy Syndrome / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
;
: 53-55, 2009.
Article
in English
| WPRIM
| ID: wpr-17143
ABSTRACT
A 58-year-old female receiving gemcitabine and cisplatin chemotherapy for stage IV gallbladder cancer developed the clinicoradiologic syndrome, posterior reversible encephalopathy syndrome (PRES). Just before the 4th gemcitabine chemotherapy cycle, she was admitted to the hospital with complaints of headache, dizziness, and generalized tonic-clonic seizures. A MRI was performed on the day when the seizure developed, and the findings showed patchy cortical and subcortical T2 hyperintensity without enhancement that involved both occipital and parietal lobes. Phenytoin loading and maintenance was started for prevention of recurrent seizures, which was successful. The follow-up brain MRI obtained 10 days after the seizure attack showed completely resolved radiologic findings. After the MRI findings revealed complete resolution, phenytoin maintenance was stopped. Even with discontinuation of phenytoin, she had no seizures or other clinical manifestations.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Parietal Lobe
/
Phenytoin
/
Seizures
/
Brain
/
Follow-Up Studies
/
Cisplatin
/
Deoxycytidine
/
Dizziness
/
Gallbladder Neoplasms
/
Headache
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Cancer Research and Treatment
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS